Tirzepatide
US$ 23.15
fda tirzepatide announcement π¨ Alert: No Longer on FDA's Drug Shortage List As of October 2, 2024, the has announced that the Tirzepatide shortage has been resolved. This means that all doses of FDA declares Mounjaro, Zepbound shortage
Description
Do not rely on memory
You may give other people a serious infection or get a serious infection from them
A seven-day gap between medications is unlikely to cause meaningful weight gain
Many patients view this as a long-term tool because obesity is a chronic metabolic condition
Drawn syringes are generally stable for 24 hours when refrigerated, though check with your specific pharmacy for their guidance
